Public Profile

Sandoz Canada Inc.

Sandoz Canada Inc., a prominent subsidiary of the global healthcare leader Novartis, is headquartered in Canada and operates extensively across the country. Founded in 1886, Sandoz has established itself as a key player in the pharmaceutical industry, specialising in generic and biosimilar medicines. The company is renowned for its commitment to high-quality, affordable healthcare solutions, offering a diverse portfolio that includes injectable medications, oral therapies, and complex generics. With a strong focus on innovation, Sandoz Canada has achieved significant milestones, including the launch of several groundbreaking biosimilars that enhance patient access to essential treatments. As a leader in the Canadian market, Sandoz is dedicated to improving patient outcomes while maintaining a robust pipeline of products that address unmet medical needs.

DitchCarbon Score

How does Sandoz Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sandoz Canada Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Sandoz Canada Inc.'s reported carbon emissions

Sandoz Canada Inc. currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing greenhouse gas emissions, but specific details regarding Sandoz Canada's climate commitments remain unspecified.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sandoz Canada Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sandoz Canada Inc. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sandoz Canada Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

GlaxoSmithKline Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astrazeneca Canada Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Pharmascience Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Novartis Pharmaceuticals Canada Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers